Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 0.90% is 110% above its 5-year average of -8.96%, near the high end of its 5-year range (-91.78%–11.29%).
As of the fiscal period ended Tuesday, March 31, 2026. 84.10% below its 12-month average of 5.67%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
0.90%
EBITDA MARGIN AVG TTM
5.67%
EBITDA MARGIN AVG 3Y
3.04%
EBITDA MARGIN AVG 5Y
-4.82%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-84.10%
CURRENT VS 3Y AVG
-70.34%
CURRENT VS 5Y AVG
+118.70%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Hims & Hers Health, Inc.
Market Cap
$6.19B
EBITDA Margin
0.90%
TTM Avg
5.67%
3Y Avg
3.04%
5Y Avg
-4.82%
Market Cap
$7.69B
EBITDA Margin
-18.44%
TTM Avg
-56.37%
3Y Avg
-54.16%
5Y Avg
-65.42%
Market Cap
$8.09B
EBITDA Margin
-3.14%
TTM Avg
-1.08%
3Y Avg
-5.02%
5Y Avg
-19.32%
Market Cap
$8.80B
EBITDA Margin
18.42%
TTM Avg
17.41%
3Y Avg
19.12%
5Y Avg
20.05%
Market Cap
$2.68B
EBITDA Margin
16.41%
TTM Avg
1.22%
3Y Avg
-1.65%
5Y Avg
4.31%
Market Cap
$2.64B
EBITDA Margin
22.42%
TTM Avg
17.70%
3Y Avg
-0.76%
5Y Avg
-37.34%
Market Cap
$10.20B
EBITDA Margin
15.05%
TTM Avg
14.69%
3Y Avg
13.35%
5Y Avg
14.10%
Market Cap
$10.21B
EBITDA Margin
2.15%
TTM Avg
3.41%
3Y Avg
4.20%
5Y Avg
4.49%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hims & Hers Health, Inc. (HIMS) | $6.19B | 0.90% | 5.67% | 3.04% | -4.82% |
| Tempus AI, Inc. (TEM)vs › | $7.69B | -18.44% | -56.37% | -54.16% | -65.42% |
| Oscar Health, Inc. (OSCR)vs › | $8.09B | -3.14% | -1.08% | -5.02% | -19.32% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.80B | 18.42% | 17.41% | 19.12% | 20.05% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.68B | 16.41% | 1.22% | -1.65% | 4.31% |
| TransMedics Group, Inc. (TMDX)vs › | $2.64B | 22.42% | 17.70% | -0.76% | -37.34% |
| Henry Schein, Inc. (HSIC)vs › | $9.77B | 8.11% | 8.11% | 8.28% | 8.19% |
| Universal Health Services, Inc. (UHS)vs › | $10.20B | 15.05% | 14.69% | 13.35% | 14.10% |
| Molina Healthcare, Inc. (MOH)vs › | $10.21B | 2.15% | 3.41% | 4.20% | 4.49% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -7.87% | -5.60% | -1.35% | 0.44% |
Gross Margin
67.6%
EBITDA Margin
0.9%
Operating Margin
1.3%
Net Margin
-0.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-31 | 0.90% |
| 2025-12-31 | 4.42% |
| 2025-09-30 | 4.92% |
| 2025-06-30 | 6.83% |
| 2025-03-31 | 11.29% |
| 2024-12-31 | 5.12% |
| 2024-09-30 | 6.66% |
| 2024-06-30 | 4.65% |
| 2024-03-31 | 4.64% |
| 2023-12-31 | 0.92% |
| 2023-09-30 | -2.73% |
| 2023-06-30 | -3.30% |
| 2023-03-31 | -4.79% |
| 2022-12-31 | -5.74% |
| 2022-09-30 | -12.48% |
| 2022-06-30 | -16.18% |
| 2022-03-31 | -14.98% |
| 2021-12-31 | -23.54% |
| 2021-09-30 | -35.21% |
| 2021-06-30 | -27.85% |
| 2021-03-31 | -91.78% |
| 2020-12-31 | -10.28% |
| 2020-09-30 | -7.31% |
| 2020-06-30 | -2.14% |
| 2020-03-31 | -20.08% |
| 2019-12-31 | -54.04% |
| 2019-09-30 | -89.60% |
| 2019-06-30 | -114.50% |
| 2019-03-31 | -114.50% |
